Abeona Therapeutics to Participate in the Jefferies Cell and Genetic Medicine Summit
NEW YORK and CLEVELAND, Sept. 22, 2022 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq:ABEO) today announced that Vish Seshadri, Chief Executive Officer of Abeona, will participate in a fireside chat at the Jefferies Cell and Genetic Medicine Summit on Friday, September 30, 2022 at 8:30 a.m. ET. The Company will also participate in one-on-one investor meetings at the conference.
Related news for (ABEO)
- Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Abeona Therapeutics® to Present at the Jefferies Global Healthcare Conference
- Abeona Therapeutics® Reports First Quarter 2025 Financial Results and Corporate Updates
- Abeona Therapeutics® and Lurie Children’s Open First Center for ZEVASKYNTM Gene Therapy to Treat Wounds in Painful Skin Disorder
- UPDATE — Abeona Therapeutics® and Lurie Children’s Open First Center for ZEVASKYN™ Gene Therapy to Treat Wounds in Painful Skin Disorder